Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F4ZaMdRni3PQPP8jG5u4d2D-M3YQ.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has added information about 3 more interventions/treatments and updated the study to include 73 locations, while also revising the version from v2.9.7 to v2.10.0.SummaryDifference0.5%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check26 days agoChange DetectedThe value 'Last Update Posted (Estimated)' has been changed to 'Last Update Posted'. This change indicates that the last update posted on the webpage is now based on actual data rather than an estimated date.SummaryDifference0.0%
- Check28 days agoChange DetectedThe value that was previously listed as Last Update Posted on 2024-01-22 has been updated to Last Update Posted (Estimated) on 2024-06-28. This change indicates a recent update in the study record information related to the clinical trial for evaluating the efficacy and safety of pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen in recurrent or metastatic head and neck squamous cell carcinoma.SummaryDifference0.6%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.